255 related articles for article (PubMed ID: 10506108)
1. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.
Pentland AP; Schoggins JW; Scott GA; Khan KN; Han R
Carcinogenesis; 1999 Oct; 20(10):1939-44. PubMed ID: 10506108
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ
Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.
Fischer SM; Conti CJ; Viner J; Aldaz CM; Lubet RA
Carcinogenesis; 2003 May; 24(5):945-52. PubMed ID: 12771040
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Wilgus TA; Koki AT; Zweifel BS; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Sep; 38(1):33-9. PubMed ID: 12949841
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Wilgus TA; Koki AT; Zweifel BS; Kusewitt DF; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Oct; 38(2):49-58. PubMed ID: 14502644
[TBL] [Abstract][Full Text] [Related]
6. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Wilgus TA; Ross MS; Parrett ML; Oberyszyn TM
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):367-84. PubMed ID: 11060900
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice.
Riedel SB; Fischer SM; Sanders BG; Kline K
Anticancer Drugs; 2008 Feb; 19(2):175-81. PubMed ID: 18176114
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches.
An KP; Athar M; Tang X; Katiyar SK; Russo J; Beech J; Aszterbaum M; Kopelovich L; Epstein EH; Mukhtar H; Bickers DR
Photochem Photobiol; 2002 Jul; 76(1):73-80. PubMed ID: 12126310
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model.
Orengo IF; Gerguis J; Phillips R; Guevara A; Lewis AT; Black HS
Arch Dermatol; 2002 Jun; 138(6):751-5. PubMed ID: 12056955
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice.
Tang X; Kim AL; Kopelovich L; Bickers DR; Athar M
Photochem Photobiol; 2008; 84(2):522-7. PubMed ID: 18266822
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor.
Wilgus TA; Parrett ML; Ross MS; Tober KL; Robertson FM; Oberyszyn TM
Adv Exp Med Biol; 2002; 507():85-92. PubMed ID: 12664569
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
16. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of silymarin against photocarcinogenesis in a mouse skin model.
Katiyar SK; Korman NJ; Mukhtar H; Agarwal R
J Natl Cancer Inst; 1997 Apr; 89(8):556-66. PubMed ID: 9106644
[TBL] [Abstract][Full Text] [Related]
18. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
[TBL] [Abstract][Full Text] [Related]
19. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
Fong LY; Zhang L; Jiang Y; Farber JL
J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
